Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia 4Leukemia, Myeloid, Acute 3Neutropenia 2Leukemia, Myelomonocytic, Acute 2Leukemia, Monocytic, Acute 2Leukemia, Megakaryoblastic, Acute 2Leukemia, Erythroblastic, Acute 2Recurrence 1Myelodysplastic Syndromes 1Leukemia, Promyelocytic, Acute 1Anemia, Refractory, with Excess of Blasts 1

Interventions

Tretinoin 12Arsenic Trioxide 7Methotrexate 5Mercaptopurine 5Cytarabine 5Idarubicin 4Mitoxantrone 3Thioguanine 2Radiotherapy 2Etoposide 2Daunorubicin 2Cyclophosphamide 2sargramostim 1merphos 1flt3 ligand protein 1Peripheral Blood Stem Cell Transplantation 1Maintenance 1Hydroxyurea 1Filgrastim 1Busulfan 1Amsacrine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Leukemia, Promyelocytic, Acute × Amsacrine × Clear all
NCT00002658 2013-12-19

Combination Chemotherapy, Biological Therapy, and Bone Marrow Transplantation in Treating Patients With Acute Myeloid Leukemia

National Cancer Institute (NCI)

Phase 3 Unknown
2,000 enrolled
Other hematologic neoplasm

Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Neutropenia, Leukemia, Myeloid, Acute, Leukemia, Promyelocytic, Acute, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡